- Home
- BOX vs OGN Comparison
BOX vs OGN Comparison
Compare BOX & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOX
- OGN
- Stock Information
- Founded
- BOX 2005
- OGN 1923
- Country
- BOX United States
- OGN United States
- Employees
- BOX N/A
- OGN N/A
- Industry
- BOX Computer Software: Prepackaged Software
- OGN Biotechnology: Pharmaceutical Preparations
- Sector
- BOX Technology
- OGN Health Care
- Exchange
- BOX Nasdaq
- OGN Nasdaq
- Market Cap
- BOX 4.6B
- OGN 3.9B
- IPO Year
- BOX 2015
- OGN N/A
- Fundamental
- Price
- BOX $32.05
- OGN $14.51
- Analyst Decision
- BOX Strong Buy
- OGN Hold
- Analyst Count
- BOX 10
- OGN 3
- Target Price
- BOX $34.60
- OGN $21.33
- AVG Volume (30 Days)
- BOX 2.2M
- OGN 2.9M
- Earning Date
- BOX 12-03-2024
- OGN 02-13-2025
- Dividend Yield
- BOX N/A
- OGN 7.66%
- EPS Growth
- BOX 299.10
- OGN 120.97
- EPS
- BOX 0.80
- OGN 5.04
- Revenue
- BOX $1,073,488,000.00
- OGN $6,409,000,000.00
- Revenue This Year
- BOX $5.90
- OGN $3.11
- Revenue Next Year
- BOX $6.37
- OGN $2.55
- P/E Ratio
- BOX $39.96
- OGN $2.89
- Revenue Growth
- BOX 4.09
- OGN 4.21
- 52 Week Low
- BOX $24.28
- OGN $13.14
- 52 Week High
- BOX $35.74
- OGN $23.10
- Technical
- Relative Strength Index (RSI)
- BOX 50.22
- OGN 36.43
- Support Level
- BOX $31.90
- OGN $14.80
- Resistance Level
- BOX $33.20
- OGN $15.41
- Average True Range (ATR)
- BOX 0.75
- OGN 0.54
- MACD
- BOX -0.13
- OGN -0.01
- Stochastic Oscillator
- BOX 42.17
- OGN 0.30
About BOX Box Inc.
Box is a cloud-based content services platform that provides cloud-based storage and workflow collaboration services for enterprise customers. The firm was founded in 2005 as a file-sync and sharing provider. More recently, however, the company has focused on bolstering its product portfolio by adding tools such as governance and e-signature to enhance workflow management and collaboration.
About OGN Organon & Co.
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.